«This study is important, in part because we now have
a new xenograft model that will for the first time allow us to apply new biomarkers to better predict disease progression and test new therapeutics.»
Not exact matches
In a 1988 paper summarizing his findings, Fiebig concluded that
xenograft mice were wonderful
models for broadly testing
new drugs against human tumors, but they «can not be used as a clinical routine method» for predicting patient treatment.1 The idea of using
xenograft mice as personal avatars for cancer patients was discarded.
NCI's efforts to develop
new laboratory
models of human cancer includes vastly increasing the number of human cancer cell lines (grown as two - dimensional and three - dimensional cultures) and patient - derived tumor
xenografts.
Since starting her
new role as an investigator in the In Vivo Pharmacology group at Novartis Oncology, Bhang has been working on using the ClonTracer library to monitor clonal dynamics following drug treatment in cell line and primary tumor
xenograft models.
Therefore, our NSIN mice provide a
new platform for
xenograft mouse
models in basic and translational research.